Human Genome Epidemiology Literature Finder
Records 1 - 8 (of 8 Records) |
Query Trace: Breast Neoplasms and HOXB13[original query] |
---|
Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistance. Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Sep 14 (18): 5864-8. Goetz Matthew P, Suman Vera J, Couch Fergus J, Ames Matthew M, Rae James M, Erlander Mark G, Ma Xiao-Jun, Sgroi Dennis C, Reynolds Carol A, Lingle Wilma L, Weinshilboum Richard M, Flockhart David A, Desta Zeruesenay, Perez Edith A, Ingle James |
The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer. Breast cancer research and treatment 2012 Dec 136 (3): 907-9. Akbari Mohammad R, Klu?niak Wojciech, Rodin Rachelle, Li Song, Woko?orczyk Dominika, Royer Robert, Kashyap Aniruddh, Menkiszak Janusz, Lubinski Jan, Narod Steven A, Cybulski Ceza |
HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013 Jan . Laitinen VH, Wahlfors T, Saaristo L, Rantapero T, Pelttari LM, Kilpivaara O, Laasanen SL, Kallioniemi A, Nevanlinna H, Aaltonen LA, Vessella RL, Auvinen A, Visakorpi T, Tammela TL, Schleutker J |
[Update on genetic predisposition to prostate cancer]. Bulletin du cancer 2015 1 102 (1): 53-6. Cussenot Olivier, Cancel-Tassin Géraldi |
Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk. Scientific reports 2016 6 30026. Liu Jingjing, Prager-van der Smissen Wendy J C, Schmidt Marjanka K, Collée J Margriet, Cornelissen Sten, Lamping Roy, Nieuwlaat Anja, Foekens John A, Hooning Maartje J, Verhoef Senno, van den Ouweland Ans M W, Hogervorst Frans B L, Martens John W M, Hollestelle Antoinet |
Pathogenic Germline DNA Repair Gene and HOXB13 Mutations in Men With Metastatic Prostate Cancer. JCO precision oncology 2020 4 . Boyle Julie L, Hahn Andrew W, Kapron Ashley L, Kohlmann Wendy, Greenberg Samantha E, Parnell Timothy J, Teerlink Craig C, Maughan Benjamin L, Feng Bing-Jian, Cannon-Albright Lisa, Agarwal Neeraj, Cooney Kathleen |
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk. Scientific reports 2020 6 10 (1): 9688. Liu Jingjing, Prager-van der Smissen Wendy J C, Collée J Margriet, Bolla Manjeet K, Wang Qin, Michailidou Kyriaki, Dennis Joe, Ahearn Thomas U, Aittomäki Kristiina, Ambrosone Christine B, Andrulis Irene L, Anton-Culver Hoda, Antonenkova Natalia N, Arndt Volker, Arnold Norbert, Aronson Kristan J, Augustinsson Annelie, Auvinen Päivi, Becher Heiko, Beckmann Matthias W, Behrens Sabine, Bermisheva Marina, Bernstein Leslie, Bogdanova Natalia V, Bogdanova-Markov Nadja, Bojesen Stig E, Brauch Hiltrud, Brenner Hermann, Briceno Ignacio, Brucker Sara Y, Brüning Thomas, Burwinkel Barbara, Cai Qiuyin, Cai Hui, Campa Daniele, Canzian Federico, Castelao Jose E, Chang-Claude Jenny, Chanock Stephen J, Choi Ji-Yeob, Christiaens Melissa, Clarke Christine L, , Couch Fergus J, Czene Kamila, Daly Mary B, Devilee Peter, Dos-Santos-Silva Isabel, Dwek Miriam, Eccles Diana M, Eliassen A Heather, Fasching Peter A, Figueroa Jonine, Flyger Henrik, Fritschi Lin, Gago-Dominguez Manuela, Gapstur Susan M, García-Closas Montserrat, García-Sáenz José A, Gaudet Mia M, Giles Graham G, Goldberg Mark S, Goldgar David E, Guénel Pascal, Haiman Christopher A, Håkansson Niclas, Hall Per, Harrington Patricia A, Hart Steven N, Hartman Mikael, Hillemanns Peter, Hopper John L, Hou Ming-Feng, Hunter David J, Huo Dezheng, , Ito Hidemi, Iwasaki Motoki, Jakimovska Milena, Jakubowska Anna, John Esther M, Kaaks Rudolf, Kang Daehee, Keeman Renske, Khusnutdinova Elza, Kim Sung-Won, Kraft Peter, Kristensen Vessela N, Kurian Allison W, Le Marchand Loic, Li Jingmei, Lindblom Annika, Lophatananon Artitaya, Luben Robert N, Lubi?ski Jan, Mannermaa Arto, Manoochehri Mehdi, Manoukian Siranoush, Margolin Sara, Mariapun Shivaani, Matsuo Keitaro, Maurer Tabea, Mavroudis Dimitrios, Meindl Alfons, Menon Usha, Milne Roger L, Muir Kenneth, Mulligan Anna Marie, Neuhausen Susan L, Nevanlinna Heli, Offit Kenneth, Olopade Olufunmilayo I, Olson Janet E, Olsson Håkan, Orr Nick, Park Sue K, Peterlongo Paolo, Peto Julian, Plaseska-Karanfilska Dijana, Presneau Nadege, Rack Brigitte, Rau-Murthy Rohini, Rennert Gad, Rennert Hedy S, Rhenius Valerie, Romero Atocha, Ruebner Matthias, Saloustros Emmanouil, Schmutzler Rita K, Schneeweiss Andreas, Scott Christopher, Shah Mitul, Shen Chen-Yang, Shu Xiao-Ou, Simard Jacques, Sohn Christof, Southey Melissa C, Spinelli John J, Tamimi Rulla M, Tapper William J, Teo Soo H, Terry Mary Beth, Torres Diana, Truong Thérèse, Untch Michael, Vachon Celine M, van Asperen Christi J, Wolk Alicja, Yamaji Taiki, Zheng Wei, Ziogas Argyrios, Ziv Elad, Torres-Mejía Gabriela, Dörk Thilo, Swerdlow Anthony J, Hamann Ute, Schmidt Marjanka K, Dunning Alison M, Pharoah Paul D P, Easton Douglas F, Hooning Maartje J, Martens John W M, Hollestelle Antoinet |
Characteristics of Germline Non-BRCA Mutation Status of High-Risk Breast Cancer Patients in China and Correlation with High-Risk Factors and Multigene Testing Suggestions. Frontiers in genetics 2021 12 12 674094. Su Yifan, Yao Qianlan, Xu Yuyin, Yu Chengli, Zhang Jing, Wang Qian, Li Jiwei, Shi Di, Yu Baohua, Zeng Yupeng, Zhu Xiaoli, Bai Qianming, Zhou Xiaoy |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 13, 2024
- Content source: